And IGM, as you mentioned ... which said they were infected -- -- if you now do a -- a rapid antigen or antibody test, and it's negative, then you should do it again. Because if that person ...

IGM is doing so after imvotamab failed to deplete B cell counts — its therapeutic goal — as effectively as the company had hoped in early-stage tests in rheumatoid arthritis and lupus.

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM ...

HLA testing has been a staple in transplantation ... The new solid-phase technologies can easily distinguish between HLA IgM and IgG antibodies by using a secondary antibody that is specific ...

The company now lists a lone, Sanofi-partnered IgM antibody asset on its pipeline ... it pivots from an in-house to outsourced analytical testing model. Those moves, coupled with other ...

Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

an IgM-based CD20 X CD3 bispecific antibody T cell engager, and IGM-2644, an IgM-based CD38 X CD3 bispecific antibody T cell engager, for autoimmune diseases. "Interim data from the Phase 1b ...

Obtain a new specimen for IgG and IgM testing. If the new specimen result remains the same, the patient is probably not infected with Toxoplasma gondii. Negative Positive Possible acute infection ...